Covid-19… The Gift That Just Won’t Quit Giving: Market Commentary from Cabana’s CEO – December 1, 2021

2 months ago

  • Share this:

The emergence of a new coronavirus strain dubbed Omicron sent world stock markets into freefall late last week. Whether this new threat sets us back economically remains to be seen. Initial reports suggest the variant is more transmissible than Delta and is likely to be less responsive to vaccination and treatment. The good news is that the early patients experienced “very mild symptoms”. To me, that is the most important consideration of all. Treatment and vaccination are rendered largely irrelevant if the disease is overall benign. The jury is still out on all this and will likely remain so for the next two weeks as scientists around the world get their heads around it.  

We have pointed out that stocks were overbought and imbalanced internally, with fewer and fewer sectors participating in recent rallies. Markets had become increasingly volatile heading into the Thanksgiving holiday and the new Omicron variant knocked us completely off the horse on Friday in one fell swoop. After a rally attempt Monday, Federal Reserve Chairman Jerome Powell testified to Congress on Tuesday that he feels the Fed should consider accelerating its taper program despite any new threat posed by Covid. This was not well received by investors and markets immediately sold off and the major indices ended down between 1.5% and 2% for the day, thereby erasing all of November’s gains in two trading days (Friday and Tuesday). 

So, where do we go from here? There is no way to know, but I can tell you what I think. If it turns out that Omicron results in only mild illness, then I think the market will bounce straight back up and we will finish the year at all-time highs. Of course, if the vaccines and current treatments (including the soon to be approved pill) for serious illness still work, we get the same positive result. I would even go so far as to say that the Omicron variant could be a positive overall if it doesn’t cause severe illness. In that case it could produce antibodies in exposed people who then would have protection theoretically against the variants that do cause severe illness.  

Now with all of that said, if the Omicron variant does produce severe illness and proves capable of evading current vaccines and treatment, then I believe the financial markets have room to fall until new vaccines are rolled out. In such a case, I don’t see a bear market on the horizon, but a 10% correction or more is on the table.  

Disclaimers

February 23, 2021

This material is prepared by Cabana LLC, dba Cabana Asset Management and/or its affiliates (together “Cabana”) for informational purposes only and is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. This material may only be distributed in its original format and may not be altered or reproduced without the prior written consent of CabanaThe opinions expressed reflect the judgement of the author, are as of the date of its publication and may change as subsequent conditions vary. The information and opinions contained in this material are derived from proprietary and nonproprietary sources deemed by Cabana to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Cabana, its officers, employees or agents.  

This material may contain ‘forward looking’ information that is not purely historical in nature. Such information may include, among other things, projections and forecasts. There is no guarantee that any forecasts made will come to pass. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not a reliable indicator of current or future results and should not be the sole factor of consideration when selecting a product or strategy. All investment strategies have the potential for profit or loss. All strategies have different degrees of risk. There is no guarantee that any specific investment or strategy will be suitable or profitable for a particular client. The information provided here is neither tax nor legal advice. Investors should speak to their tax professional for specific information regarding their tax situation. Investment involves risk including possible loss of principal.  

Cabana LLC, dba Cabana Asset Management (“Cabana”), is an SEC registered investment adviser with offices in Fayetteville, AR and Plano, TX. The firm only transacts business in states where it is properly registered or is exempted from registration requirements. Registration as an investment adviser is not an endorsement of the firm by securities regulators and does not mean the adviser has achieved a specific level of skill or ability. Additional information regarding Cabana, including its fees, can be found in Cabana’s Form ADV, Part 2. A copy of which is available upon request or online at www.adviserinfo.sec.gov/. 

Past performance is no guarantee of future results. All investment strategies have different degrees of risk and the corresponding potential for profit or loss. Asset allocation and diversification will not necessarily improve returns and cannot eliminate the risk of investment losses. “Target Drawdown” is merely a descriptive term used to describe the general strategy and objective of the portfolio, it is not a guarantee, nor should it be construed to suggest safety or protection from loss. There is no guarantee that portfolio performance will remain consistent with the targeted drawdown parameter. While risk tolerance and targeted “drawdown” are identified on the front end for each portfolio, Cabana’s algorithm does not take any one client’s situation into account and there is no guarantee that Cabana’s strategies will be suitable for any investor. Investors and advisors should not simply rely on the name of any portfolio to determine what is suitable. It is the responsibility of investment advisors to determine what is suitable for their clients. Cabana manages assets on multiple custodial platforms. Performance results for specific investors will vary based upon differences in associated costs and asset availability.  

Cabana claims compliance with the Global Investment Performance Standards (GIPS®). GIPS® is a trademark of the CFA Institute. The CFA Institute does not endorse or promote this organization, nor does it warrant the accuracy or quality of the content contained herein. To receive a GIPS Report and/or a firm’s list of composite/pooled fund descriptions please email your request to info@thecabanagroup.com.

The COVID-19 health epidemic has had substantial global economic impact on financial markets. As of March of 2020, restrictions to travel and business spanning the economy for activities not deemed essential have been imposed throughout the United States. These restrictions have caused unprecedented volatility and uncertainty in capital markets and have negatively impacted the economy. It is unknown how severe the impact to the economy and capital markets will be if the epidemic persists for an extended period of time. The epidemic may have a material adverse impact on Cabana’s investment advisory business including, but not limited to, the performance of our portfolio strategies.  

For additional information regarding our services, including performance disclosures and award methodology, please visit https://thecabanagroup.com/disclaimers/.